NCT02587364View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

September 30, 1999

Study Completion Date

September 30, 1999

Conditions
Hypercholesterolemia
Interventions
DRUG

Gemcabene 50 mg

Gemcabene 50 mg once daily (QD)

DRUG

Gemcabene 150 mg

Gemcabene 150 mg once daily (QD)

DRUG

Gemcabene 450 mg

Gemcabene 450 mg once daily (QD)

DRUG

Gemcabene 750/600 mg

Gemcabene 750/600 mg once daily (QD)

DRUG

Gemcabene 900 mg

Gemcabene 900 mg once daily (QD)

DRUG

Placebo

Placebo once daily (QD)

Sponsors
All Listed Sponsors
lead

NeuroBo Pharmaceuticals Inc.

INDUSTRY